Royalty Pharma Price to Free Cash Flow Ratio 2019-2021 | RPRX

Historical price to free cash flow ratio values for Royalty Pharma (RPRX) since 2019. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Royalty Pharma Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2021-09-27 37.15 0.00
2021-06-30 40.81 $-0.87 0.00
2021-03-31 43.25 $-0.36 0.00
Sector Industry Market Cap Revenue
Finance Finance - Miscellaneous Services $22.556B $2.122B
Royalty Pharma plc is a funder of biopharmaceutical industry. The compnay's portfolio includes royalties on commercial products, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta and Vertex's Kalydeco, Symdeko and Trikafta, and development-stage product candidates. Royalty Pharma plc is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
American Express (AXP) United States $140.432B 23.26
Blackstone (BX) United States $84.605B 34.84
Moody's (MCO) United States $68.559B 30.99
Synchrony Financial (SYF) United States $29.465B 8.90
Orix Corp Ads (IX) Japan $24.174B 12.50
Lufax Holding (LU) China $17.729B 7.06
Equitable Holdings (EQH) United States $12.584B 5.33
Jefferies Financial Group (JEF) United States $9.350B 6.72
Globe Life (GL) United States $9.255B 13.24
Houlihan Lokey (HLI) United States $6.528B 18.31
Owl Rock Capital (ORCC) United States $5.664B 12.24
CIT Group (CIT) United States $5.305B 7.76
CI Financial (CIXX) Canada $4.249B 0.00
AXOS FINANCIAL, INC (AX) United States $2.889B 13.19
LendingClub (LC) United States $2.881B 0.00
Intercorp Financial Services (IFS) Peru $2.650B 5.77
Fortress Transportation And Infrastructure Investors LLC (FTAI) United States $2.184B 0.00
PJT Partners (PJT) United States $1.961B 15.67
PPDAI Group (FINV) China $1.622B 4.77
Guild Holdings (GHLD) $0.861B 0.00
X Financial (XYF) China $0.231B 0.00
Lument Finance Trust (LFT) United States $0.103B 9.58
Burford Capital (BUR) $0.000B 0.00